News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Research
In highly lethal type of leukemia, cancer gene predicts treatment response
Patients with the most lethal form of acute myeloid leukemia (AML) – based on genetic profiles of their cancers – typically survive for only four to six months after diagnosis, even with aggressive chemotherapy. But new research indicates that such patients, paradoxically, may live longer if they receive a milder chemotherapy drug. Treatment with the […]
Research
New topical immunotherapy effective against early skin cancer
A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the therapy activates the immune system’s T cells, which then attack […]
Research
Weight loss may help prevent multiple myeloma
New research shows that excess weight increases the risk that a benign blood disorder will progress into multiple myeloma, a cancer of the blood. The study, by a team at Washington University School of Medicine in St. Louis, is published Nov. 18 in the Journal of the National Cancer Institute. Being overweight or obese has […]
Staff/Faculty Update
Achilefu named to chemistry, optical societies
Samuel Achilefu, PhD, the Michel M. Ter-Pogossian Professor of Radiology at Washington University School of Medicine in St. Louis, has been elected as a fellow to the Royal Society of Chemistry and to The Optical Society. The Royal Society of Chemistry is a London-based professional association of chemical scientists with more than 50,000 members worldwide. […]
Research
Siteman fund grants $300,000 for unique approaches to fighting cancer
Two scientists at Washington University School of Medicine in St. Louis and Siteman Cancer Center will receive a combined $300,000 in funding over two years for their innovative approaches to fighting cancer. The awards, from the Alvin J. Siteman Cancer Research Fund, are meant to further promising early-stage science that because of its unconventional approach […]
In the Media
Siteman Cancer Center benefits from QVC Presents “FFANY Shoes on Sale”
QVC and FFANY present a contribution of $300,000 as a result of charitable multiplatform event For more than 20 years, QVC Presents “FFANY Shoes on Sale” has combined great shopping with an even better cause. Last October during the annual charitable shoe sale, more than 80,000 pairs of shoes were purchased at half the manufacturer’s […]
Research
Even with genetic predisposition for lung cancer, quitting smoking reduces risk
Quitting smoking improves health and lowers odds of developing lung cancer. But a new study shows that even among smokers with a genetic predisposition to smoking heavily and developing lung cancer at a young age, the benefits of quitting are significant. An international study led by researchers at Washington University School of Medicine in St. […]
Prevention
Excess weight linked to 8 more cancer types
There’s yet another reason to maintain a healthy weight as we age. An international team of researchers has identified eight additional types of cancer linked to excess weight and obesity: stomach, liver, gall bladder, pancreas, ovary, meningioma (a type of brain tumor), thyroid cancer and the blood cancer multiple myeloma. Limiting weight gain over the […]
Research
$10.4 million awarded for pancreatic cancer research
The National Cancer Institute (NCI) has awarded a $10.4 million, five-year grant to Washington University researchers and physicians at Siteman Cancer Center to lead a national group of experts in collaborative pancreatic cancer research. The award, a prestigious Specialized Program of Research Excellence (SPORE) grant, will help scientists pursue new treatments for the deadliest form […]
Research
New study shows breast tumors evolve in response to hormone therapy
Many breast tumors grow in response to female hormones, especially estrogen. Drugs that reduce estrogen levels in the body often are effective in reducing tumor size and preventing recurrence of the cancer. But some tumors become resistant to these therapies and continue to grow and spread. A new analysis of breast tumors, before and after […]